论文信息 - Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial - 字舞流文

Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial

D. Purcell | K. Subbarao | Thi H. O. Nguyen | K. Kedzierska | T. Munro | P. Reading | L. Hensen | P. Young | P. Ellenberg | P. Hogarth | B. Wines | S. Nicholson | P. Griffin | D. Watterson | D. Wijesundara | C. Ranasinghe | K. Chappell | A. Chung | P. Tapley | Stacey T M Cheung | M. Tran | J. Bennet | F. Mordant | Kym Hoger | K. Selva | Zheyi Li | M. Avumegah | N. Modhiran | J. Lackenby | Christina L. Henderson | Wuji Zhang | Sara Marrero-Hernández | James Barnes | Stavroula Corby | T. Holgate | S. Marrero-Hernández | Naphak Modhiran | Keith J. Chappell | S. Corby